GlassScriptPhysician profile
Michael Braimah Saaka
NPI 1396720470
$16,634.17
in general payments reported to CMS, 2019-2025
14 companies · $12K in 2025
The $12K reported for 2025 was more than what 91% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.47 · 2020: $262 · 2021: $1,488 · 2022: $290 · 2023: $673 · 2024: $2,229 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $12K · Food and Beverage: $2,098.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $12,460.76 |
| Food and Beverage | $2,098.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $11,911.41 | 2022-2025 | Hawkone, In.Pact Admiral, Abre |
| Penumbra, INC. | $1,964.62 | 2020-2025 | Indigo System, Penumbra System |
| Silk Road Medical, INC. | $1,555.32 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Shockwave Medical, INC | $313.53 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher |
| Boston Scientific Corporation | $197.40 | 2025 | Enroute Transcarotid Neuroprotection System |
| Endologix LLC | $170.66 | 2020 | |
| Cardiovascular Systems INC. | $133.75 | 2020-2022 | |
| W. L. Gore & Associates, INC. | $122.28 | 2022-2024 | Excluder Conformable Aaa Endoprosthesis With Active Control |
| Abbott Laboratories | $72.84 | 2023-2025 | Perclose Prostyle, Diamondback Peripheral |
| Janssen Pharmaceuticals, INC | $58.27 | 2020-2024 | Xarelto |
| Acera Surgical, INC. | $47.93 | 2023 | Restrata Wound Matrix |
| Intact Vascular, INC. | $34.47 | 2019 | |
| Angiodynamics, INC. | $27.67 | 2022 | |
| Bard Peripheral Vascular, INC. | $24.02 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Saaka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.